<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abstract <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is an aggressive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> with a high mortality rate; however, effective therapies are currently lacking </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e>-targeting gene-virotherapy (CTGVT) has been proposed to be a promising strategy for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to investigate the antitumor activity of the oncolytic adenovirus harboring Lipocalin-2 (ZD55-Lipocalin-2, an example of CTGVT) in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>ZD55-Lipocalin-2 was generated by deleting E1B55-KD and inserting the Lipocalin-2 gene </plain></SENT>
<SENT sid="4" pm="."><plain>Its cytopathic effects and cell growth inhibition were detected in vitro, and antitumor effects were examined in a <z:mp ids='MP_0003815'>nude</z:mp> mouse model of human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> xenografts </plain></SENT>
<SENT sid="5" pm="."><plain>Results showed that ZD55-Lipocalin-2 significantly inhibited the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> growth by selective cytolysis, inducing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and decreasing the microvessel density in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The anticancer potential of ZD55-Lipocalin-2 showed stronger than that of the isolated Lipocalin-2 gene therapy or isolated ZD55 oncolytic adenovirus therapy </plain></SENT>
<SENT sid="7" pm="."><plain>ZD55-Lipocalin-2 may serve as a potential anticancer agent for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> treatment </plain></SENT>
</text></document>